Study characteristics | Number of trials (%) |
---|---|
Publication year | |
 2016–2020 | 75 (26%) |
 2011–2015 | 52 (18%) |
 2006–2010 | 46 (16%) |
 2001–2005 | 53 (19%) |
 1996–2000 | 29 (10%) |
 Before 1996 | 32 (11%) |
Country | |
 USA | 116 (40%) |
 UK or Ireland | 35 (12%) |
 Canada | 29 (10%) |
 Australia or New Zealand | 18 (6%) |
 Other | 89 (31%) |
Number of trial arms | |
 Two | 222 (77%) |
 Three | 37 (13%) |
 Four | 25 (9%) |
 More than four | 3 (1%) |
Clinical setting | |
 Primary care | 161 (56%) |
 Hospital inpatient | 65 (23%) |
 Other outpatient clinic | 24 (8%) |
 Community care | 17 (6%) |
 Other/mixed | 20 (7%) |
Medical specialty | |
 General practitioner/family physician | 167 (58%) |
 Internists | 59 (21%) |
 Other | 61 (21%) |
Targeted healthcare professionals (could include more than one) | |
 Physician | 263 (92%) |
 Nurses | 51 (18%) |
 Pharmacists | 8 (3%) |
 Other | 43 (15%) |
Targeted healthcare professional behaviour (could include more than one) | |
 Prescribing | 139 (51%) |
 Testing/exams | 88 (32%) |
 Treatment decision/action | 53 (19%) |
 Screening | 49 (18%) |
 Counselling | 47 (17%) |
 Immunization | 26 (9%) |
 Referrals | 16 (6%) |
 Diagnosis | 11 (4%) |
 Other | 6 (2%) |